ANDA 77020, held by Ivax Sub Teva Pharms. Cilostazol.
As of Nov 16, 2026, ANDA 77020 (Cilostazol), held by Ivax Sub Teva Pharms, was first approved by FDA on Mar 1, 2005, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 1, 2005 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cilostazol100MG ยท tablet;oral | Cilostazol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters